X-115189754-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000317135.13(LRCH2):c.350-1384A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,165,678 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 26)
Exomes 𝑓: 0.000010 ( 0 hom. 1 hem. )
Consequence
LRCH2
ENST00000317135.13 intron
ENST00000317135.13 intron
Scores
17
Clinical Significance
Conservation
PhyloP100: -1.11
Genes affected
RBMXL3 (HGNC:26859): (RBMX like 3) Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be part of U12-type spliceosomal complex. [provided by Alliance of Genome Resources, Apr 2022]
LRCH2 (HGNC:29292): (leucine rich repeats and calponin homology domain containing 2) This gene encodes a member of the leucine-rich repeat and calponin homology domain-containing protein family. These family members contain multiple N-terminal leucine-rich repeats, in addition to a C-terminal calponin homology domain, a type of domain that mediates interactions with actin filaments. These proteins are conserved across animal species, and studies of a similar Drosophila protein indicate a function as a cytoskeletal scaffolding protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0499098).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBMXL3 | NM_001145346.2 | c.313T>C | p.Ser105Pro | missense_variant | 1/1 | ENST00000424776.5 | NP_001138818.1 | |
LRCH2 | NM_020871.4 | c.350-1384A>G | intron_variant | ENST00000317135.13 | NP_065922.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBMXL3 | ENST00000424776.5 | c.313T>C | p.Ser105Pro | missense_variant | 1/1 | NM_001145346.2 | ENSP00000417451 | P1 | ||
LRCH2 | ENST00000317135.13 | c.350-1384A>G | intron_variant | 1 | NM_020871.4 | ENSP00000325091 | P2 | |||
LRCH2 | ENST00000538422.2 | c.350-1384A>G | intron_variant | 1 | ENSP00000439366 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 113032Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 35196
GnomAD3 genomes
AF:
AC:
2
AN:
113032
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
35196
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000180 AC: 2AN: 111340Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 39732
GnomAD3 exomes
AF:
AC:
2
AN:
111340
Hom.:
AF XY:
AC XY:
0
AN XY:
39732
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000104 AC: 11AN: 1052646Hom.: 0 Cov.: 33 AF XY: 0.00000291 AC XY: 1AN XY: 344018
GnomAD4 exome
AF:
AC:
11
AN:
1052646
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
344018
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000177 AC: 2AN: 113032Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 35196
GnomAD4 genome
AF:
AC:
2
AN:
113032
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
35196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2024 | The c.313T>C (p.S105P) alteration is located in exon 1 (coding exon 1) of the RBMXL3 gene. This alteration results from a T to C substitution at nucleotide position 313, causing the serine (S) at amino acid position 105 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of phosphorylation at S105 (P = 0.0037);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at